Mangrove Partners’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-14,641
| Closed | -$2.83M | – | 61 |
|
|
2020
Q1 | $2.83M | Buy |
14,641
+5,209
| +55% | +$1.01M | 0.39% | 32 |
|
|
2019
Q4 | $3.15M | Sell |
9,432
-2,420
| -20% | -$808K | 0.46% | 31 |
|
|
2019
Q3 | $3.82M | Hold |
11,852
| – | – | 0.46% | 52 |
|
|
2019
Q2 | $5.11M | Buy |
11,852
+4,058
| +52% | +$1.75M | 0.58% | 35 |
|
|
2019
Q1 | $4.41M | Buy |
+7,794
| New | +$4.41M | 0.59% | 33 |
|